A Study of Oral Dosing of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients
Status:
Completed
Trial end date:
2018-06-25
Target enrollment:
Participant gender:
Summary
The objective of this study was to assess the efficacy of once-daily oral administration of
gabapentin enacarbil versus placebo, based on the change in International Restless Legs
Syndrome Rating Scale (IRLS) score in participants with moderate-to-severe idiopathic
restless legs syndrome. This study also assessed the safety of Gabapentin enacarbil.